电流失活化作为KCNQ2发育性和性脑病变的新病理机制
Ingride Luzio Gaspar1,2, Gaetano Terrone3, Giusy Carleo1
1Section of Pharmacology, Department of Neuroscience, University of Naples Federico II, Naples, Italy.
Epilepsia
|April 28, 2025
概括
新生KCNQ2变种导致重症新生儿. 这项研究确定了KCNQ2-DEE的新型失活机制,强调了体外功能评估的重要性.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 的研究研究.
背景情况:
- KCNQ2基因变异是新生儿发育和性脑病变 (KCNQ2-DEE) 的主要原因.
- 大多数KCNQ2-DEE变种导致功能丧失效应.
- 了解KCNQ2-DEE精确的分子机制对于治疗开发至关重要.
研究的目的:
- 为了研究在新生儿发病DEE的患者中发现的复发性de novoKCNQ2变体 (p.A265V) 的功能后果.
- 阐明这种特定变异引起的KCNQ2-DEE背后的病原遗传机制.
主要方法:
- 在哺乳动物异质表达系统中利用全细胞补丁电生理学.
- 同表达的野生型Kv7.2子单位与突变的Kv7.2 (A265V) 子单位,以及Kv7.2+Kv7.3子单位.
- 分析了电流密度,激活的电压依赖性和电流失活性质.
主要成果:
- 该Kv7.2 A265V变种显著降低了最大电流密度.
- A265V子单元降低了通道激活的电压依赖.
- 观察到一种不寻常的电流失活化过程,在去极化脉冲期间显著减少,取决于突变子单元的比例.
结论:
- 目前的无活化代表了KCNQ2-DEE.的新型病原遗传机制.
- 经常出现的KCNQ2变体p.A265V会影响关键的孔隙残留物,导致道功能发生改变.
- 在体外功能评估对于了解KCNQ2-DEE的分子病理生理学至关重要.
相关概念视频
The Role of Ion Channels in Neuronal Computation
3.1K
A postsynaptic neuron usually receives numerous impulses from several other presynaptic neurons. The axon hillock of the postsynaptic neuron integrates all these signals and determines the likelihood of firing an action potential.
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
3.1K
Voltage-gated Ion Channels
7.8K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
7.8K
Antiepileptic Drugs: Potassium Channel Activators
119
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
119
Non-gated Ion Channels
6.6K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.6K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
807
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
807
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.0K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.0K


